These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6676898

  • 61. A study of the levels of tobramycin and gentamicin in human serum and renal cortex and of changes in in vitro bacterial sensitivity.
    Faragó E, Guba T.
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):199-203. PubMed ID: 3403098
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. [Distribution of aminoside resistance in 430 strains of gram-negative bacilli in a hospital environment. Value of amikacine].
    Le Noc P, Croizé J.
    Sem Hop Ther; 1977 Apr; 53(7-8):378-83. PubMed ID: 244369
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. [Sensitivity of gram-negative germs to Amikacin].
    Redjeb SB, Ennaifer M, Bissardon O, Ben Salah N, Boujnah A.
    Tunis Med; 1979 Apr; 57(2-3):103-6. PubMed ID: 553336
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.
    Holm SE, Hill B, Löwestad A, Maller R, Vikerfors T.
    J Antimicrob Chemother; 1983 Oct; 12(4):393-402. PubMed ID: 6643334
    [Abstract] [Full Text] [Related]

  • 73. [Detection of the phenotypes of resistance of enterobacteriaceae to aminoglycosides with ATB Plus Expert System].
    Peyret M, Albertini MT, Olleon M, Davenas C, Blanc V.
    Pathol Biol (Paris); 1993 Apr; 41(4):329-36. PubMed ID: 8233631
    [Abstract] [Full Text] [Related]

  • 74. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E, Di Leonardo F, Giordano G, De Felice M, Cerquetti F, Vonmoos A.
    Minerva Urol; 1981 Apr; 33(2):85-90. PubMed ID: 7322100
    [No Abstract] [Full Text] [Related]

  • 75. [Comparison of the antibacterial and therapeutic activity of tobramycin, sisomycin and gentamycin].
    Shapovalova SP, Malkova IV, Liashenko VA.
    Antibiotiki; 1978 Apr; 23(4):333-7. PubMed ID: 646335
    [No Abstract] [Full Text] [Related]

  • 76. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV, Conzelman GM, Franti CE, Ruby AL.
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. [Vestibular tests in infants after treatment with aminoglycosides].
    Zagólski O.
    Pol Merkur Lekarski; 2005 Nov; 19(113):638-41. PubMed ID: 16498801
    [Abstract] [Full Text] [Related]

  • 79. [Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
    Leroy A, Oksenhendler G, Fillastre JP, Humbert G.
    J Urol Nephrol (Paris); 1977 Sep; 83(9):738-41. PubMed ID: 243544
    [No Abstract] [Full Text] [Related]

  • 80. [Proposed use of a technic based on bioluminescence for determination of the minimal inhibiting concentration (MIC)].
    Crovatto M, Chiaradia V, Ius A, De Paoli P, Santini G, Grattoni E.
    Quad Sclavo Diagn; 1981 Sep; 17(3):394-404. PubMed ID: 7045962
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.